AmplifyBio faces a lawsuit for allegedly violating layoff notification laws after closing its central Ohio facilities on April 4.

The fresh funds provided by the European Innovation Council will help the Cambridge-based company overcome technical barriers ...

AmplifyBio said in a statement April 4, saying the decision to close followed months of efforts to keep the four-year-old firm afloat.

ASX biotechs have become well-known for paediatric drug discovery with several life-altering treatments exported to the world ...

French biotech OSE Immunotherapeutics is taking charge of a new project aimed at fast-tracking nanodrug development and ...

New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...

These scents, now bottled by a new biotech perfume brand called Future Society, never touched the noses of anyone alive today ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

Chicago’s life sciences market is the smallest of any major U.S. market by square footage yet has a vacancy rate of 43.3 ...

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...

Akero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis. Click here to find out why ...

Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to ...